Pharma's Market
- Tuesday, 24 Nov 2009 12:52 PM ETBy: Mike Huckman
For the second time in three weeks I'm at a flu vaccine manufacturing plant today. Construction isn't finished on the Novartis site yet, but nonetheless they're doing the formal ribbon-cutting ceremony here in Holly Springs, NC this afternoon. » Read more - Friday, 20 Nov 2009 2:51 PM ETBy: Mike Huckman
Investors, patients and activists, no doubt, hope they won't have to put out a mayday distress call, but as Dendrama's fate would have it, the company announced today that the Food and Drug Administration has assigned May Day as its decision day for the prostate cancer treatment Provenge. » Read more - Friday, 20 Nov 2009 12:04 PM ETBy: Mike HuckmanEarlier this week I reported that Dr. Allen Taylor who ran the Abbott vs. Merck cholesterol drug study, which Abbott's drug Niaspan won, would only say that ABT has paid him more than $10,000 in lecture and consulting fees. But he wouldn't be any more specific than that. » Read more
- Wednesday, 18 Nov 2009 12:03 PM ETBy: Mike HuckmanVVUS this morning unveiled positive late-stage test results on the ED pill. The company touts that it takes effect in less than 30 minutes and it's out of your system within six hours or so. » Read more
- Tuesday, 17 Nov 2009 4:09 PM ETBy: Mike HuckmanWhen I do an interview with a clinical trial investigator I typically try to take care of what I call the "housekeeping" at the beginning or end. » Read more
- Monday, 16 Nov 2009 3:09 PM ETBy: Mike HuckmanLive TV is best when things are happening and news is breaking right now. It's immediate and often, hopefully, more compelling. » Read more
- Friday, 13 Nov 2009 11:55 AM ETBy: Mike Huckman
It doesn't always happen, but there is a common to-and-fro, push-and-pull, back-and-forth or whatever you want to call it between reporters and corporate PR folks. I don't particularly like that part of my job, but sometimes it just comes with the territory. I've got my job to do and they've got theirs. I get it. » Read more - Thursday, 12 Nov 2009 11:32 AM ETBy: Mike Huckman
Today starts a two-day FDA public hearing in Washington, DC on biopharma and social media. I decided not to go because talking heads in a meeting room just don't make for good TV. And this is just the first step in what is no doubt going to be a very long, involved policy-making process. But as it turns out, it looks like it might have been futile for me to try to attend anyway. » Read more
ABOUT PHARMA'S MARKET
Pharma's Market is more than just a play on words. Think of this blog written by Mike Huckman as a “farmer's market”—a place where you'll find a wide assortment of fresh stuff related to the drug, biotech and medical device industries. Mike will try to harvest topics from fertile, untilled ground. And yes, occasionally, he'll go off the farm.
BIO
Mike Huckman is the author of CNBC.com’s Pharma’s Market and CNBC's Pharmaceuticals Reporter covering the drug, biotechnology and medical device industries. Huckman joined the network in 2000 and is based at the network’s global headquarters in Englewood Cliffs, N.J. Read full bio here.
MIKE HUCKMAN'S FAVORITE LINKS
PHARMA'S MARKET VIDEO
» More
SPECIAL REPORT
MOST SHARED
- The Executive Job Search
- Chinese Overcapacity is Worsening, EU Chamber Warns
- Salvation Army's Kettles Now Credit Card-Ready
- US Mint to Suspend American Eagle Gold 1-Ounce Coins
- Hyundai-Kia Targets Rapid China Growth in 2010
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- China Unveils Carbon Target Ahead of Copenhagen
- Wal-Mart Price Pressure Hurts China Workers: Report
- Oil Friday
- 4 Enemies of Bull Markets
- Experiencing Technical Difficulty?
- The Importance of Good Breadth
- Your First Move For Friday November 27th
- How Big Money Rules the Markets
- Web Extra: Private Equity, Conviction Buy?
- Follow the Leader
- Pops & Drops: Abercrombie & Fitch, Nucor...
- Giving Thanks: Seymour
- Your Questions About... Alcoa & The Dollar
RSS FEED
» Help
powered by digg
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
